(HEN3) Henkel & Co. KGaA vz. (Pref - Ratings and Ratios
Adhesives, HairCare, Laundry, Cleaning, Sealants
Description: HEN3 Henkel & Co. KGaA vz. (Pref
Henkel AG & Co. KGaA is a global player in the consumer goods and adhesive technologies sectors, operating through various business segments, including packaging and consumer goods, mobility and electronics, and craftsmen, construction, and professional industries. The company has a diversified product portfolio that includes adhesives, sealants, hair care products, laundry and home care products, and household cleaners, among others. With a presence in multiple channels, including brick-and-mortar stores, hair salons, and digital platforms, Henkel has a strong global footprint.
From a financial perspective, Henkels market capitalization stands at approximately €26.6 billion, indicating a significant presence in the market. The companys price-to-earnings (P/E) ratio is around 13.99, suggesting a relatively stable valuation. Additionally, the forward P/E ratio is 12.52, indicating potential for future growth. Henkels return on equity (RoE) is 15.97%, demonstrating a decent level of profitability. Other key performance indicators (KPIs) that can be considered include revenue growth, gross margin, and dividend yield. For instance, Henkel has consistently delivered revenue growth, with a compound annual growth rate (CAGR) of around 3-4% over the past few years. The companys gross margin is also stable, ranging between 40-45%. Furthermore, Henkel has a dividend yield of around 2-3%, making it an attractive option for income-seeking investors.
To further analyze Henkels stock performance, it is essential to examine its historical trends and industry comparisons. Over the past year, the stock has experienced a decline, with a 52-week high of €84.67 and a low of €64.06. Comparing Henkels performance to its peers in the personal care products industry, the companys valuation multiples are relatively in line with industry averages. However, its profitability metrics, such as RoE, are slightly higher than those of its peers, indicating a competitive advantage.
HEN3 Stock Overview
| Market Cap in USD | 33,156m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
HEN3 Stock Ratings
| Growth Rating | -25.2% |
| Fundamental | 82.6% |
| Dividend Rating | 33.2% |
| Return 12m vs S&P 500 | -23.1% |
| Analyst Rating | - |
HEN3 Dividends
| Dividend Yield 12m | 2.76% |
| Yield on Cost 5y | 2.72% |
| Annual Growth 5y | -12.94% |
| Payout Consistency | 97.3% |
| Payout Ratio | 18.4% |
HEN3 Growth Ratios
| Growth Correlation 3m | 57% |
| Growth Correlation 12m | -66.8% |
| Growth Correlation 5y | 1.2% |
| CAGR 5y | -0.81% |
| CAGR/Max DD 5y | -0.02 |
| Sharpe Ratio 12m | -0.52 |
| Alpha | -16.63 |
| Beta | 0.163 |
| Volatility | 15.97% |
| Current Volume | 369k |
| Average Volume 20d | 417.5k |
| Stop Loss | 69.8 (-3.1%) |
| Signal | 0.36 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (3.33b TTM) > 0 and > 6% of Revenue (6% = 2.59b TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 10.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 4.51% (prev 2.97%; Δ 1.53pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 6.38b > Net Income 3.33b (YES >=105%, WARN >=100%) |
| Net Debt (1.40b) to EBITDA (6.86b) ratio: 0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (419.9m) change vs 12m ago -0.07% (target <= -2.0% for YES) |
| Gross Margin 47.94% (prev 42.75%; Δ 5.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 128.3% (prev 105.3%; Δ 23.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 16.66 (EBITDA TTM 6.86b / Interest Expense TTM 298.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.23
| (A) 0.06 = (Total Current Assets 11.03b - Total Current Liabilities 9.09b) / Total Assets 35.27b |
| (B) 0.64 = Retained Earnings (Balance) 22.62b / Total Assets 35.27b |
| (C) 0.15 = EBIT TTM 4.96b / Avg Total Assets 33.58b |
| (D) 1.70 = Book Value of Equity 22.88b / Total Liabilities 13.45b |
| Total Rating: 5.23 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.59
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 17.95% = 5.0 |
| 3. FCF Margin 11.93% = 2.98 |
| 4. Debt/Equity 0.17 = 2.49 |
| 5. Debt/Ebitda 0.54 = 2.28 |
| 6. ROIC - WACC 9.64% = 12.06 |
| 7. RoE 15.97% = 1.33 |
| 8. Rev. Trend 10.58% = 0.53 |
| 9. Rev. CAGR 3.02% = 0.38 |
| 10. EPS Trend 41.42% = 1.04 |
| 11. EPS CAGR 15.16% = 1.52 |
What is the price of HEN3 shares?
Over the past week, the price has changed by -2.52%, over one month by +5.35%, over three months by +2.15% and over the past year by -10.09%.
Is Henkel & Co. KGaA vz. (Pref a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HEN3 is around 66.70 EUR . This means that HEN3 is currently overvalued and has a potential downside of -7.44%.
Is HEN3 a buy, sell or hold?
What are the forecasts/targets for the HEN3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 81 | 12.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 72.9 | 1.1% |
HEN3 Fundamental Data Overview
Market Cap EUR = 28.46b (28.46b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 3.53b EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 14.3944
P/E Forward = 13.5501
P/S = 1.3443
P/B = 1.5107
P/EG = 3.9851
Beta = 0.45
Revenue TTM = 43.10b EUR
EBIT TTM = 4.96b EUR
EBITDA TTM = 6.86b EUR
Long Term Debt = 2.05b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.65b EUR (from shortTermDebt, last quarter)
Debt = 3.70b EUR (Calculated: Short Term 1.65b + Long Term 2.05b)
Net Debt = 1.40b EUR (from netDebt column, last quarter)
Enterprise Value = 28.63b EUR (28.46b + Debt 3.70b - CCE 3.53b)
Interest Coverage Ratio = 16.66 (Ebit TTM 4.96b / Interest Expense TTM 298.0m)
FCF Yield = 17.95% (FCF TTM 5.14b / Enterprise Value 28.63b)
FCF Margin = 11.93% (FCF TTM 5.14b / Revenue TTM 43.10b)
Net Margin = 7.71% (Net Income TTM 3.33b / Revenue TTM 43.10b)
Gross Margin = 47.94% ((Revenue TTM 43.10b - Cost of Revenue TTM 22.44b) / Revenue TTM)
Tobins Q-Ratio = 1.25 (Enterprise Value 28.63b / Book Value Of Equity 22.88b)
Interest Expense / Debt = 4.36% (Interest Expense 161.0m / Debt 3.70b)
Taxrate = 25.38% (from yearly Income Tax Expense: 691.0m / 2.72b)
NOPAT = 3.71b (EBIT 4.96b * (1 - 25.38%))
Current Ratio = 1.21 (Total Current Assets 11.03b / Total Current Liabilities 9.09b)
Debt / Equity = 0.17 (Debt 3.70b / last Quarter total Stockholder Equity 21.73b)
Debt / EBITDA = 0.54 (Net Debt 1.40b / EBITDA 6.86b)
Debt / FCF = 0.72 (Debt 3.70b / FCF TTM 5.14b)
Total Stockholder Equity = 20.82b (last 4 quarters mean)
RoA = 9.43% (Net Income 3.33b, Total Assets 35.27b )
RoE = 15.97% (Net Income TTM 3.33b / Total Stockholder Equity 20.82b)
RoCE = 21.72% (Ebit 4.96b / (Equity 20.82b + L.T.Debt 2.05b))
RoIC = 15.88% (NOPAT 3.71b / Invested Capital 23.34b)
WACC = 6.23% (E(28.46b)/V(32.16b) * Re(6.62%)) + (D(3.70b)/V(32.16b) * Rd(4.36%) * (1-Tc(0.25)))
Shares Correlation 5-Years: -87.20 | Cagr: -0.84%
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈3.63b ; Y1≈4.48b ; Y5≈7.64b
Fair Price DCF = 797.6 (DCF Value 129.90b / Shares Outstanding 162.9m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 10.58 | Revenue CAGR: 3.02%
Rev Growth-of-Growth: 32.41
EPS Correlation: 41.42 | EPS CAGR: 15.16%
EPS Growth-of-Growth: -30.55